You are here

ADA

Diabetes Tech: A Catalyst Rich Sector with a Dazzling Future

Medical Devices and Diagnostics Industry

Tue, 06/27/23 - 11:38 am

Medtronic links 780G insulin pump to benefits in kids as it works to grow sales

Medtech Dive

Tue, 06/27/23 - 11:31 am

ADA says all diabetes patients should be screened for nonalcoholic fatty liver disease

Stat

Sun, 06/25/23 - 09:43 pm

ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer

EP Vantage

Wed, 06/21/23 - 10:38 am

ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia

Fierce Pharma

Tue, 06/7/22 - 10:13 am

chronic kidney disease

ADA 2021: After strong showing for Soliqua against premixed insulin, Sanofi exec expects 'a lot of interest' among doctors

Fierce Pharma

Mon, 06/28/21 - 10:53 am

Study: Pfizer's Experimental Diabetes Drug Robustly Reduces Weight and Glucose

BioSpace

Tue, 06/16/20 - 07:02 pm

ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers

Fierce Pharma

Tue, 06/16/20 - 06:59 pm

ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function

Fierce Pharma

Mon, 06/15/20 - 11:10 pm

chronic kidney disease

Why MannKind Stock Crushed it Monday

Motley Fool

Mon, 06/15/20 - 11:03 pm

inhaled insulin

ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show

Fierce Pharma

Sun, 06/14/20 - 08:14 pm

ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar

Fierce Pharma

Sun, 06/14/20 - 08:06 pm

type 2 diabetes

ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2

Fierce Pharma

Sun, 06/14/20 - 08:05 pm

Key data on Medtronic's 780G, Insulet's Horizon kick off ADA 2020

Medtech Dive

Fri, 06/12/20 - 08:09 pm

Horizon insulin delivery system

Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease

Endpoints

Wed, 06/12/19 - 10:02 am

cardiovascular disease

ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study

Fierce Pharma

Tue, 06/11/19 - 12:06 pm

Boehringer Ingelheim

Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial

Biopharma Dive

Mon, 06/10/19 - 07:34 pm

clinical trials

Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show

BioSpace

Mon, 06/10/19 - 04:26 pm

clinical trials

type 1 diabetes

ADA: AstraZeneca's Farxiga scores in kidney outcomes study

Fierce Pharma

Mon, 06/10/19 - 09:44 am

clinical trials

Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist

Fierce Biotech

Mon, 06/10/19 - 09:39 am

type 2 diabetes

Pages